Back to Search
THOMAS HUGHES, MD
MD
Gastroenterology Physician
NPI: 1659310910Individual
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
28220(NC)
Research & Publications (20)
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Emerging therapies for metabolic diseases--the focus is on diabetes and obesity.
PMID 19482541·Curr Opin Chem Biol·2009
6-review
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
PMID 17940526·Nat Clin Pract Oncol·2008
8-other
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
Adaptive management of the Great Barrier Reef and the Grand Canyon world heritage areas.
PMID 18074897·Ambio·2007
8-other
Evaluating dosage compensation as a cause of duplicate gene retention in Paramecium tetraurelia.
PMID 17521457·Genome Biol·2007
6-review
Phase shifts, herbivory, and the resilience of coral reefs to climate change.
PMID 17291763·Curr Biol·2007
7-preclinical
Childhood risk factors for alcohol abuse and psychological distress among adult lesbians.
PMID 17628667·Child Abuse Negl·2007
8-other
Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
PMID 16324916·Metabolism·2006
2-rct
ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring.
PMID 17124063·Hematology Am Soc Hematol Educ Program·2006
6-review
Underestimation of mortality due to chronic obstructive pulmonary disease (COPD) in Kentucky.
PMID 16939035·J Ky Med Assoc·2006
4-observational
Regions of alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid receptor subunits that are permissive for the insertion of green fluorescent protein.
PMID 16765522·Neuroscience·2006
4-observational
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
PMID 16522812·Blood·2006
6-review
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
PMID 16426942·Blood Rev·2006
6-review
Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancer.
PMID 15885887·Cancer Lett·2006
8-other
Alcohol use and alcohol-related problems among lesbians and gay men.
PMID 16353369·Annu Rev Nurs Res·2005
6-review
E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.
PMID 15766563·Biochem Biophys Res Commun·2005
8-other
Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA.
PMID 15611123·J Biol Chem·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11 MEDICAL PARK DR
LEXINGTON, NC 27292 - Phone
- (336) 249-2800
Quick Facts
- NPI
- 1659310910
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile